RUTW250102C1920000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
Nasdaq, S&P, and Dow Closed Mostly Higher to Start the Shortened Trading Week
The Nuclear Option For AI
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Arcturus Therapeutics Announces Initiation Of Dosing In Phase 2 Multiple Ascending Dose Studies For Cystic Fibrosis And Ornithine Transcarbamylase Deficiency; Phase 2 Interim Data For Both MRNA Therapeutic Programs On Track For First Half Of 2025
ACELYRIN Announces Additional Phase 2 Data And Phase 3 Program Design For Lonigutamab In Thyroid Eye Disease; Patients Demonstrate Potential For Efficacy In Line With Standard Of Care And A More Favorable Safety Profile
4 Analysts Have This To Say About Commercial Metals
Neumora Therapeutics Shares Are Trading Higher. B of A Securities Maintained a Buy Rating on the Stock.
Forestar Group Analyst Ratings
Crypto-Related Shares Are Surging Today: What's Going On?
'LDH Reports First U.S. H5N1-Related Human Death' - Louisiana Department Of Health
Bumble Shares Are On The Rise Today: What You Need To Know
Optimum-MSGN Standoff Could Pressure MSG Networks' Finances: Analyst
Inari Medical Shares Resume Trade
Inari Medical Shares Halted On Circuit Breaker To The Upside, Stock Now Up 5.81%
EXCLUSIVE: Rocket Lab, Intuitive Machines, Redwire Or AST SpaceMobile? 33% Of Readers Pick This Space Stock For 2025
Peering Into NuScale Power's Recent Short Interest
High Quality Cyclical Stocks According to Morgan Stanley
Options Corner: Betting On A Near-Term Pullback In D-Wave Quantum
Riley Exploration Unveils Gas Purchase Deal, Midstream Buildout for New Mexico Assets
Asana Analyst Ratings